Humana Inc . (NYSE:HUM), a leading player in the U.S. healthcare sector, is navigating a complex landscape of challenges and opportunities as it seeks to maintain its strong position in the Medicare ...

Health insurance company Humana (NYSE:HUM) announced in Q4 CY2024, with sales up 13.5% year on year to $29.21 billion. The company’s full-year revenue guidance of $127 billion at the midpoint came in ...

Humana Inc . (NYSE:HUM), a leading player in the U.S. healthcare sector, is navigating a complex landscape of challenges and opportunities as it seeks to maintain its strong position in the ...

Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new strategies, and market outlook.

Humana reported a Q4 revenue beat at $29.19 billion but saw an adjusted EPS loss. The insurer forecasts 2025 sales of up to $128 billion and a 10% Medicare Advantage decline.

Humana attributes the expected slowdown to factors that won't repeat in 2025, such as the impact of the “two-midnight” rule, though it still expects high specialty drug costs. The company also noted ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25 ...